Successful sequential therapy with rituximab and daratumumab for
refractory post-transplant immune thrombocytopenic purpura
- Katsutsugu Umeda
, - Yuki Shino,
- Yoshinori Uchihara,
- Kazuki Mitani,
- Keiji Tasaka,
- Hideto Ogata,
- Hirokazu Kobushi,
- Satoshi Saida,
- Itaru Kato,
- Takeshi Yoshida,
- Atsushi Yokoyama,
- Hidefumi Hiramatsu,
- Junko Takita
Katsutsugu Umeda
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Corresponding Author:umeume@kuhp.kyoto-u.ac.jp
Author ProfileYuki Shino
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author ProfileYoshinori Uchihara
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author ProfileKazuki Mitani
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author ProfileKeiji Tasaka
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author ProfileHideto Ogata
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author ProfileHirokazu Kobushi
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author ProfileSatoshi Saida
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author ProfileItaru Kato
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author ProfileTakeshi Yoshida
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author ProfileAtsushi Yokoyama
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author ProfileHidefumi Hiramatsu
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author ProfileJunko Takita
Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu Hattatsu Shoni Kagaku
Author Profile28 Apr 2023Submitted to Pediatric Blood & Cancer 28 Apr 2023Submission Checks Completed
28 Apr 2023Assigned to Editor
28 Apr 2023Review(s) Completed, Editorial Evaluation Pending
28 Apr 2023Editorial Decision: Revise Minor
12 May 20231st Revision Received
12 May 2023Submission Checks Completed
12 May 2023Assigned to Editor
12 May 2023Review(s) Completed, Editorial Evaluation Pending
15 May 2023Editorial Decision: Accept
